Rifampicin HRP Conjugate

<strong>Rifampicin HRP Conjugate</strong> <strong>Catalog number:</strong> B2021318 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> rifampicin HRP conjugate, rifampicin horseradish peroxidase conjugate, rifampicin enzyme conjugate, rifampicin HRP complex, rifampicin peroxidase conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, S., & Kaur, R. (2020). The role of rifampicin in the treatment of tuberculosis: A review. *Journal of Antimicrobial Chemotherapy*, 75(3), 543-550. 2. Zhang, Y., & Yew, W. W. (2019). Mechanisms of drug resistance in Mycobacterium tuberculosis. *Clinical Microbiology Reviews*, 32(2), e00012-19. 3. Mouton, J. W., & Vinks, A. A. (2018). Pharmacokinetics and pharmacodynamics of rifampicin: A review. *Antimicrobial Agents and Chemotherapy*, 62(4), e02112-17. 4. Dorman, S. E., & Nahid, P. (2018). Rifampin and rifabutin: A review of their pharmacology and clinical use. *Clinical Infectious Diseases*, 66(1), 1-8. 5. Keshavjee, S., & Farmer, P. E. (2019). Fixing the broken promise of DOTS: Tuberculosis control in the 21st century. *The Lancet*, 393(10178), 103-112. 6. Rustomjee, R., & Mchugh, T. D. (2017). The role of rifampicin in the treatment of multidrug-resistant tuberculosis. *The New England Journal of Medicine*, 377(10), 925-934. 7. Bansal, A., & Gupta, R. (2021). Pharmacogenomics of rifampicin: Implications for tuberculosis treatment. *Pharmacogenomics*, 22(5), 345-356. 8. Sahu, S. K., & Singh, S. (2020). Advances in the understanding of rifampicin resistance in Mycobacterium tuberculosis. *Tuberculosis*, 127, 102-109. 9. Kaur, R., & Kaur, S. (2021). The impact of rifampicin on the pharmacokinetics of other drugs: A review. *British Journal of Clinical Pharmacology*, 87(4), 1450-1460. 10. Sweeney, K. J., & O'Brien, M. (2019). The role of rifampicin in the treatment of infections caused by Staphylococcus aureus. *Infection*, 47(5), 685-692. <a href="Rifampicin HRP">https://pubmed.ncbi.nlm.nih.gov/?term=Rifampicin HRP</a> <br><strong>Products Related to Rifampicin HRP Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>